About ACGT
Erkki Ruoslahti, M.D., Ph.D.
Distinguished Professor
The Burnham Institute Adjunct Professor of Bioengineering,
University of California at San Diego,
La Jolla, California
Distinguished Professor
The Burnham Institute Adjunct Professor of Bioengineering,
University of California at San Diego,
La Jolla, California
Recently, Dr. Ruoslahti has made innovative use of libraries of phage-displayed peptides to study the heterogeneity of the vasculature. This technology has revealed an astonishing degree of diversity in the vascular system, including specific markers of tumor vasculature and the vasculature of pre-malignant lesions. The RGD sequence and the new phage-derived homing peptides show promise as targeting elements for drugs and gene therapy vectors.
Dr. Ruoslahti is the author of more than 400 research papers and a member of the US National Academy of Sciences and the Institute of Medicine, and a recipient of the 2005 Japan Prize in Cell Biology.
< Return to Scientific Advisory Council
©2007 Alliance for Cancer Gene Therapy 96 Cummings Point Road, Stamford, CT, 06902